chr22-18169868-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_017414.4(USP18):c.652C>T(p.Gln218Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 30)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
USP18
NM_017414.4 stop_gained
NM_017414.4 stop_gained
Scores
4
2
1
Clinical Significance
Conservation
PhyloP100: 2.88
Genes affected
USP18 (HGNC:12616): (ubiquitin specific peptidase 18) The protein encoded by this gene belongs to the ubiquitin-specific proteases (UBP) family of enzymes that cleave ubiquitin from ubiquitinated protein substrates. It is highly expressed in liver and thymus, and is localized to the nucleus. This protein efficiently cleaves only ISG15 (a ubiquitin-like protein) fusions, and deletion of this gene in mice results in a massive increase of ISG15 conjugates in tissues, indicating that this protein is a major ISG15-specific protease. Mice lacking this gene are also hypersensitive to interferon, suggesting a function of this protein in downregulating interferon responses, independent of its isopeptidase activity towards ISG15. [provided by RefSeq, Sep 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 22-18169868-C-T is Pathogenic according to our data. Variant chr22-18169868-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 417774.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
USP18 | NM_017414.4 | c.652C>T | p.Gln218Ter | stop_gained | 7/11 | ENST00000215794.8 | |
USP18 | XM_006724074.4 | c.430C>T | p.Gln144Ter | stop_gained | 6/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
USP18 | ENST00000215794.8 | c.652C>T | p.Gln218Ter | stop_gained | 7/11 | 1 | NM_017414.4 | P1 | |
USP18 | ENST00000699060.1 | c.652C>T | p.Gln218Ter | stop_gained | 7/10 | ||||
USP18 | ENST00000699061.1 | n.398C>T | non_coding_transcript_exon_variant | 4/6 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD3 genomes
Cov.:
30
GnomAD4 exome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 1452348Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 721344
GnomAD4 exome
Data not reliable, filtered out with message: AC0;AS_VQSR
AF:
AC:
0
AN:
1452348
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
721344
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 30
GnomAD4 genome
Cov.:
30
Bravo
AF:
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Pseudo-TORCH syndrome 2 Pathogenic:2
Likely pathogenic, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | May 02, 2023 | The heterozygous p.Gln218Ter variant in USP18 was identified by our study, in the compound heterozygous state with a likely pathogenic variant (ClinVar Variation ID: 417775), in two siblings with pseudo-TORCH syndrome 2 (PMID: 27325888). Familial exome analysis revealed that this variant was in trans with a likely pathogenic variant (ClinVar Variation ID: 417775). These individuals along with 3 homozygous affected siblings from another family, were reported in the literature (PMID: 27325888). Of these 5 affected individuals (PMID: 27325888), 3 were homozygotes and 2 were compound heterozygotes who carried a likely pathogenic variant (ClinVar Variation ID: 417775) in trans, which increases the likelihood that the p.Gln218Ter variant is pathogenic. This variant has also been reported in ClinVar (Variation ID: 417774) and has been interpreted as pathogenic by OMIM. This variant was absent from large population studies. This nonsense variant leads to a premature termination codon at position 218, which is predicted to lead to a truncated or absent protein. Loss of function of the USP18 gene is strongly associated to autosomal recessive pseudo-TORCH syndrome 2 (PMID: 27325888). In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal recessive pseudo-TORCH syndrome 2. ACMG/AMP Criteria applied: PVS1_Strong, PM2_Supporting, PM3, PP1 (Richards 2015). - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 26, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
MutationTaster
Benign
A
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at